| 256 |
Inhibition of mitochondrial DNA polymerase gamma leading to kidney toxicity |
Angela Mally |
BY-SA |
1481: Inhibition of mitochondrial DNA polymerase gamma (Pol gamma)
|
814: Occurrence, Kidney toxicity
|
Under Development |
1.43 |
| 257 |
Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity |
Angela Mally |
BY-SA |
1486: Binding of substrate, endocytic receptor
|
814: Occurrence, Kidney toxicity
|
Under Development |
1.43 |
| 258 |
Renal protein alkylation leading to kidney toxicity |
Angela Mally |
BY-SA |
244: Alkylation, Protein
|
814: Occurrence, Kidney toxicity
|
Under Development |
1.43 |
| 151 |
AhR activation leading to preeclampsia |
Sabrina Tait |
BY-SA |
18: Activation, AhR
|
1893: increase, Preeclampsia
|
Under Development |
1.42 |
| 152 |
Interference with thyroid serum binding protein transthyretin and subsequent adverse human neurodevelopmental toxicity |
Kristie Sullivan |
BY-SA |
957: Binding, Transthyretin in serum
|
402: Cognitive function, decreased
|
Under Development |
1.41 |
| 128 |
Kidney dysfunction by decreased thyroid hormone |
Jung-Hwa Oh |
BY-SA |
277: Thyroid hormone synthesis, Decreased
|
814: Occurrence, Kidney toxicity
|
Under Development |
1.40 |
| 130 |
Phospholipase A2 (LPLA2) inhibitors leading to hepatotoxicity |
Jung-Hwa Oh |
BY-SA |
828: Inhibition, Phospholipase A
|
840: Formation, Liver fibrosis
|
Under Development |
1.39 |
| 154 |
Inhibition of Calcineurin Activity Leading to Impaired T-Cell Dependent Antibody Response |
Takumi Ohishi |
BY-SA |
980: Inhibition, Calcineurin Activity
|
984: Impairment, T-cell dependent antibody response
|
WPHA/WNT Endorsed |
1.38 |
| 155 |
Deiodinase 2 inhibition leading to increased mortality via reduced posterior swim bladder inflation |
Dries Knapen |
BY-SA |
1002: Inhibition, Deiodinase 2
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 156 |
Deiodinase 2 inhibition leading to increased mortality via reduced anterior swim bladder inflation |
Dries Knapen |
BY-SA |
1002: Inhibition, Deiodinase 2
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 157 |
Deiodinase 1 inhibition leading to increased mortality via reduced posterior swim bladder inflation |
Dries Knapen |
BY-SA |
1009: Inhibition, Deiodinase 1
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 158 |
Deiodinase 1 inhibition leading to increased mortality via reduced anterior swim bladder inflation |
Dries Knapen |
BY-SA |
1009: Inhibition, Deiodinase 1
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 159 |
Thyroperoxidase inhibition leading to increased mortality via reduced anterior swim bladder inflation |
Dries Knapen |
BY-SA |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
WPHA/WNT Endorsed |
1.35 |
| 363 |
Thyroperoxidase inhibition leading to altered visual function via altered retinal layer structure |
Lucia Vergauwen |
BY-SA |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
Under Review |
1.35 |
| 364 |
Thyroperoxidase inhibition leading to altered visual function via decreased eye size |
Lucia Vergauwen |
All rights reserved |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
Under Development |
1.35 |
| 365 |
Thyroperoxidase inhibition leading to altered visual function via altered photoreceptor patterning |
Lucia Vergauwen |
All rights reserved |
279: Thyroperoxidase, Inhibition
|
2 AOs
|
Under Development |
1.35 |
| 3 |
Inhibition of the mitochondrial complex I of nigro-striatal neurons leads to parkinsonian motor deficits |
Andrea Terron |
BY-SA |
888: Binding of inhibitor, NADH-ubiquinone oxidoreductase (complex I)
|
896: Parkinsonian motor deficits
|
WPHA/WNT Endorsed |
1.33 |
| 173 |
Substance interaction with the pulmonary resident cell membrane components leading to pulmonary fibrosis |
Sabina Halappanavar |
BY-SA |
1495: Substance interaction with the lung resident cell membrane components
|
1458: Pulmonary fibrosis
|
WPHA/WNT Endorsed |
1.32 |
| 187 |
Anticoagulant rodenticide inhibition of vitamin K epoxide reductase resulting coagulopathy and hemorrhage |
Undefined |
BY-SA |
3 MIEs
|
1136: Impaired recruitment , Population trajectory
|
Under Development |
1.31 |
| 16 |
Acetylcholinesterase inhibition leading to acute mortality |
Dan Villeneuve |
BY-SA |
12: Acetylcholinesterase (AchE) Inhibition
|
2 AOs
|
Under Development |
1.3 |
| 54 |
Inhibition of Na+/I- symporter (NIS) leads to learning and memory impairment |
Anna Price |
BY-SA |
424: Inhibition, Na+/I- symporter (NIS)
|
341: Impairment, Learning and memory
|
WPHA/WNT Endorsed |
1.28 |
| 21 |
Aryl hydrocarbon receptor activation leading to early life stage mortality, via increased COX-2 |
Markus Hecker |
BY-SA |
18: Activation, AhR
|
None
|
WPHA/WNT Endorsed |
1.27 |
| 455 |
Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced impeded craniofacial development |
Prarthana Shankar |
BY-SA |
18: Activation, AhR
|
2 AOs
|
WPHA/WNT Endorsed |
1.27 |
| 456 |
Aryl hydrocarbon receptor activation leading to early life stage mortality via sox9 repression induced cardiovascular toxicity |
Prarthana Shankar |
BY-SA |
18: Activation, AhR
|
947: Increase, Early Life Stage Mortality
|
WPHA/WNT Endorsed |
1.27 |
| 117 |
Androgen receptor activation leading to hepatocellular adenomas and carcinomas (in mouse and rat) |
Charles Wood |
Open for adoption |
25: Agonism, Androgen receptor
|
719: Increase, hepatocellular adenomas and carcinomas
|
Under Development |
1.26 |